On September 30, 2023, the veterinary community lost a pillar in the feline medicine speciality, Elizabeth Colleran, DVM, DABVP (feline practice). Colleran was a renowned cat expert and spoke to veterinarians worldwide through books, articles, interviews, and lectures, helping to make the world a better place for cats and get them the care that they […]
Zlatko59 / stock.adobe.com Primary bone tumors arise directly from bone and may include osteosarcoma, chondrosarcoma, and fibrosarcoma, among other types of neoplasia. Osteosarcoma is the most common primary bone tumor in dogs, representing 85% to 98% of all bone tumors.1,2 Bone tumors may arise in either the appendicular or axial skeleton, with 75% of tumors […]
Colorectal Cancer © stock.adobe.com A new drug application (NDA) seeking the approval of fruquintinib (Elunate) for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC) has been submitted to Japan’s Ministry of Health, Labour, and Welfare.1 The NDA is supported by data from the phase 3 FRESCO-2 trial (NCT04322539), as well as […]
Latest Interim Data from a Multi-Institutional Study Builds Upon Growing Evidence of A GammaTile® Therapy As Safe and Effective Treatment for Patients with Brain Tumors TEMPE, Ariz., Oct. 2, 2023 /PRNewswire/ — GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, today announced interim findings of […]
The American Hospital Association (AHA) Coding Clinic for the third quarter of 2023 was recently published. There was a question regarding post-molar pregnancy gestational trophoblastic disease/gestational trophoblastic neoplasia (GTD/GTN). The provider’s final diagnoses were Stage III GTN, multiple bilateral metastatic nodules of the lung, adnexal mass, and presumed vaginal lesion. The questioner noted that “malignant […]
Patient organizations hold a unique position of influence, serving as drivers of change when it comes to advocating for the patient experience among regulators, those powering clinical developments, policymakers and leaders in the healthcare industry. Through a hands-on approach of investing in and leading initiatives, their primary objective is to ensure the effective allocation of […]
Prophylactic donor lymphocyte infusion (pro-DLI) for prevention of graft vs host disease (GVHD) after haploidentical hematopoietic cell transplantation (haplo-HCT) with posttransplant cyclophosphamide (PTCy) is safe and efficacious in pediatric patients with high-risk myeloid neoplasms, according to research published in Pediatric Blood & Cancer. Researchers conducted a retrospective observational study to evaluate the efficacy and safety […]
This release summarises the diagnoses in 2021 registered by NDRS covering all registerable neoplasms (all cancers, all in situ tumours, some benign tumours and all tumours that have uncertain or unknown behaviours) Release date: 19 October 2023 9:30am (confirmed) These statistics will be released on 19 October 2023 9:30am
Abstract Purpose Magnetic resonance imaging (MRI) has deeply altered the prostate biopsy strategy to detect prostate cancer. However, it is still debatable whether the detection rate differs between transrectal (TR) and transperineal (TP) MRI-targeted biopsy (MRI-TB). To compare the effectiveness of these two methods for detecting both overall prostate cancer (PCa) and clinically significant PCa […]
Of the 561 articles identified, 17 were included: 1 randomized clinical trial (RCT) [15], 6 observational studies [10,11,12, 19,20,21] and 10 case reports [22,23,24,25,26,27,28,29,30,31] (Fig. 1). Five hundred and twenty-eight articles were excluded, as they did not address the PTLDS. The selection process is detailed in Fig. 1. Tables 1 and 2 detail the lead author, year of […]